Skip to main content
BDSX
NASDAQ Industrial Applications And Services

Biodesix 10-Q: Q3 Revenue $24.0M, Net Loss Narrows to $8.0M, Cash $28.4M

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Diagnostics & Research Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$16
Mkt Cap
$209.334M
52W Low
$5.26
52W High
$31.97
52W Position info
204% above low
Off High info
50% below high
Rel. Volume info
1.6× avg
Market data snapshot near publication time

BDSX has more than doubled off its 52-week low of $5.26.

Summary

Biodesix's Q3 10-Q shows $24.0 million of revenue (up 10% but below the $27.5 million estimate), an $8.0 million net loss, and $28.4 million of cash after heavy ATM use; full-year guidance was cut to $101 million-$103 million.


Key Events · Earnings and Guidance · BDSX

  • Q3 Revenue Misses Consensus

    Total revenue of $24.041 million rose 10% year over year but came in about 13% below the $27.5 million IBES estimate. Diagnostic Testing grew 16% to $23.055 million, while Development Services fell 49% to $0.986 million.

  • Full-Year Guidance Cut

    The 2026 revenue outlook was revised to $101 million-$103 million, with the midpoint implying roughly 15% growth over 2025. The cut reflects Q3 results, sales team expansion timing and delayed Development Services contracts.

  • Loss Narrows, Cash at $28.4M

    Net loss of $8.032 million improved 8% from $8.716 million a year ago. Cash and cash equivalents were $28.409 million at September 30, 2026, up from $18.987 million at year-end 2025.

  • Heavy ATM Use Drives Share Growth

    Nine-month ATM sales totaled $30.4 million gross (2,460,441 shares at a $12.38 weighted average), lifting shares outstanding to 11.05 million from 8.25 million at December 31, 2025. At quarter-end, $12.2 million of ATM capacity remained.


Analysis · BDSX · Industrial Applications And Services

The 10-Q fills in the numbers behind today's 8-K and guidance cut. Revenue of $24.041 million rose 10% year over year but fell short of the $27.5 million consensus, and the full-year outlook was trimmed to $101 million-$103 million. The quarter's net loss narrowed to $8.032 million from $8.716 million, and cash stood at $28.409 million at quarter-end after $6.6 million of gross ATM proceeds in Q3. On the balance sheet, $50.0 million of Perceptive term debt carries a roughly 12.92% rate, with maturity pushed out to November 21, 2028. Dilution is already visible in the share count: 11.05 million shares outstanding versus 8.25 million at year-end 2025, reflecting $30.4 million of nine-month ATM sales and 228,691 shares issued on Perceptive's cashless warrant exercise.

How filings like this one have moved

In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, BDSX was trading at $16.00 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $209.3M. The 52-week trading range was $5.26 to $31.97. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

BDSX - Latest Insights

BDSX
Nov 12, 2026, 9:29 AM EST
Filing Type: SCHEDULE 13D/A
Importance Score:
7
Price at Filing: $10.12
Real-time Price: $7.56 info
Change: -$2.56 (-25%) info
Market Cap: $83.829M info
BDSX
Nov 12, 2026, 9:29 AM EST
Filing Type: 4
Importance Score:
7
Price at Filing: $10.12
Real-time Price: $7.56 info
Change: -$2.56 (-25%) info
Market Cap: $83.829M info
BDSX
Nov 06, 2026, 3:24 AM EST
Source: Benzinga
Importance Score:
7
Price at Filing: $11.61
Real-time Price: $7.56 info
Change: -$4.05 (-35%) info
Market Cap: $83.829M info
BDSX
Nov 05, 2026, 4:03 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $18.70
Real-time Price: $7.56 info
Change: -$11.14 (-60%) info
Market Cap: $83.829M info
BDSX
Nov 05, 2026, 4:02 PM EST
Source: Reuters
Importance Score:
7
Price at Filing: $18.70
Real-time Price: $7.56 info
Change: -$11.14 (-60%) info
Market Cap: $83.829M info